Suppr超能文献

脊索瘤中的角蛋白亚群和单克隆抗体HBME-1:模拟脊索瘤的肿瘤之间的免疫组化鉴别诊断

Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma.

作者信息

O'Hara B J, Paetau A, Miettinen M

机构信息

Department of Anatomy, Pathology and Cell Biology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.

出版信息

Hum Pathol. 1998 Feb;29(2):119-26. doi: 10.1016/s0046-8177(98)90220-9.

Abstract

Thirty-five chordomas and more than 100 other tumors that have to be considered in the differential diagnosis, were immunohistochemically analyzed using a panel of antibodies including those to subsets of keratins (K), HBME-1, a monoclonal antibody recognizing an unknown antigen on mesothelial cells, and neuroendocrine markers. The patterns of immunoreactivities in chordoma were compared with those in renal cell carcinoma, colorectal mucinous adenocarcinoma, pituitary adenoma, skeletal chondrosarcoma, and extraskeletal myxoid chondrosarcoma (ESMC). Chordomas were consistently positive for keratin cocktail AE1/AE3, and for the individual keratins K8 and K19, and nearly always positive for K5, but they showed negative or only sporadic reactivity for K7 and K20. The keratin K8 and K19 reactivity was retained in those chordomas showing solid sheets of epithelioid, spindle cells, or cartilaginous metaplasia, and in one of two cases showing overtly sarcomatous transformation. In comparison, keratins were never present in skeletal chondrosarcoma, although K8 and to a lesser extent K19 were seen in occasional cases of ESMC with chordoid features. HBME-1 reacted strongly with chordoma and skeletal chondrosarcoma but was almost never positive in renal or colorectal carcinoma. These carcinomas lacked K5-reactivity, in contrast to chordoma. Chordomas were also consistently positive for neuron-specific enolase and occasionally focally for synaptophysin, but never for chromogranin. In contrast, pituitary adenomas regularly expressed the full spectrum of neuroendocrine markers and differed from chordoma by having a narrower repertoire of keratins, often showing negative or focal keratin 8- or AE1/AE3 reactivity and being almost always K19-negative. These findings indicate that chordoma can be immunohistochemically separated from tumors that can resemble it. Immunohistochemistry is especially useful in the diagnosis of small biopsy specimens that offer limited material for morphological observation.

摘要

对35例脊索瘤以及100多例在鉴别诊断中需考虑的其他肿瘤进行免疫组织化学分析,所用抗体组合包括针对角蛋白(K)亚群、HBME-1(一种识别间皮细胞上未知抗原的单克隆抗体)以及神经内分泌标志物的抗体。将脊索瘤的免疫反应模式与肾细胞癌、结直肠黏液腺癌、垂体腺瘤、骨软骨肉瘤和骨外黏液样软骨肉瘤(ESMC)的免疫反应模式进行比较。脊索瘤对角蛋白混合物AE1/AE3、单个角蛋白K8和K19始终呈阳性,对K5几乎总是呈阳性,但对K7和K20呈阴性或仅呈散在反应。角蛋白K8和K19的反应性在那些呈现上皮样、梭形细胞实性片层或软骨化生的脊索瘤中得以保留,在两例显示明显肉瘤样转化的病例中的一例中也得以保留。相比之下,骨软骨肉瘤中从未检测到角蛋白,尽管在偶尔具有脊索样特征的ESMC病例中可见K8,且K19的表达程度较低。HBME-1与脊索瘤和骨软骨肉瘤反应强烈,但在肾癌或结直肠癌中几乎从不呈阳性。与脊索瘤相反,这些癌缺乏K5反应性。脊索瘤对神经元特异性烯醇化酶也始终呈阳性,偶尔对突触素呈局灶性阳性,但对嗜铬粒蛋白从不呈阳性。相比之下,垂体腺瘤通常表达全套神经内分泌标志物,与脊索瘤不同的是,其角蛋白谱较窄,常呈阴性或局灶性角蛋白8或AE1/AE3反应性,且几乎总是K19阴性。这些发现表明,脊索瘤可通过免疫组织化学与可能与之相似的肿瘤区分开来。免疫组织化学在诊断小活检标本时特别有用,因为这些标本可供形态学观察的材料有限。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验